Clinical trial Recruiting at 10 sites Observational Ages 18 and up

Observing the natural progression of RFC1 repeat expansion disease

Official title: RFC1 Natural History Study

Run by University Hospital Tuebingen · NCT05177809 · Data updated 2026-11-12

This study is trying to understand how RFC1 repeat expansion disease affects people over time and to find helpful markers for diagnosis and future treatments.

More Ataxia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital Tuebingen
Academic / other
Locations10 sites (Melbourne, Victoria and 9 other locations)
StatusRecruiting
StartedDecember 14, 2021
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMarch 31, 2026
Trial IDNCT05177809 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a genetic diagnosis of bi-allelic pathogenic repeat expansions in RFC1.

Probably not a fit

Patients with evidence of neuropathy, neurodegenerative disease, or movement disorders, as well as those unable to provide informed consent, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international, multi-center observational study aims to explore the phenotypic spectrum and natural progression of RFC1 repeat expansion disease, a form of ataxia that typically presents in late adulthood. Participants will undergo annual assessments that include standardized clinical examinations and optional biosample donations for biomarker analysis. The study will utilize a clinical database to track data and outcomes, while also potentially incorporating various additional examinations to capture the disease's multisystemic effects. The goal is to identify reliable biomarkers that can aid in diagnosis and serve as outcome measures for future clinical trials.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and outcome measures for patients with RFC1 repeat expansion disease.

How similar studies have gone: While this study employs a novel approach to understanding RFC1 repeat expansion disease, similar observational studies have shown success in characterizing other genetic ataxias.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* RFC1: genetic diagnosis of bi-allelic pathogenic repeat expansions in RFC1
* Unrelated healthy controls: no signs or history of neurological or psychiatric disease AND
* Written informed consent AND
* Participants are willing and able to comply with study procedures

Exclusion Criteria:

* RFC1: Missing informed consent
* Controls: evidence of neuropathy, neurodegenerative disease, or movement disorder; inability to give informed consent

Where it's running

  • Department of Neuroscience, Central Clinical School, Monash University
    Melbourne, Victoria, Australia
    Recruiting
  • Department of Neurology, Ataxia Unit, Universidade Federal de São Paulo
    São Paulo, State of São Paulo, Brazil
    Recruiting
  • Service de Neurologie, Hôpitaux Universitaires de Strasbourg
    Strasbourg, Strasbourg, France
    Recruiting
  • Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases
    Tübingen, Baden-Wurttemberg, Germany
    Recruiting
  • German Center for Neurodegenerative Diseases (DZNE)
    Bonn, North Rhine-Westphalia, Germany
    Recruiting
  • Department of Neurology University Hospital Schleswig Holstein
    Lübeck, Schleswig-Holstein, Germany
    Recruiting
Show 4 more locations
  • Università degli Studi di Napoli 'Federico II', c/o AOU Federico II
    Naples, Napoli, Italy
    Recruiting
  • IRCCS Fondazione Stella Maris
    Pisa, Italy
    Recruiting
  • Centre of Brain Research Neurogenetics Research Clinic, University of Auckland
    Auckland, New Zealand
    Recruiting
  • Koç University Hospital, KUTTAM-NDAL
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How foot braces might help people with ataxia walk better

    This study tests whether wearing foot orthoses at home can improve gait and balance for adults with cerebellar ataxia.

    Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07720700

  • Registry and natural history of epilepsy-dyskinesia syndromes

    This registry will collect health data and biological samples from people of all ages who have a genetic diagnosis of epilepsy-dyskinesia syndromes to see how their genes relate to their movement and seizure symptoms over time.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06967727

  • Registry and biobank for neuroimmunological diseases

    This study is trying to see if certain antibodies in the brain are linked to neurological disorders like encephalopathy and psychosis, and how they might affect patients' health.

    Recruiting at 2 sites Charite University, Berlin, Germany · Berlin, State of Berlin and 1 other locations · NCT06958341

  • Home-based training for improving gait and balance in movement disorders

    This study is testing whether a three-week home training program can help people with movement disorders like ataxia and Parkinson's improve their balance and walking.

    Recruiting Forschungszentrum Juelich · Düsseldorf, North Rhine-Westphalia · NCT06617884

  • Understanding epilepsy-dyskinesia syndromes in children

    This study is trying to learn more about epilepsy-dyskinesia syndromes in children by gathering information from different countries to see how these movement and seizure disorders are related.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06585605

  • Cerebellar tACS plus iTBS combined with exercise for ataxia balance

    This test will see if combining cerebellar tACS and iTBS with guided exergaming improves balance in people with ataxia.

    Recruiting LIFE - Research and Care Institute - Santa Lucia IRCCS · Rome, Lazio · NCT06420271

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.